Sun Pharma Advanced Research Company (SPARC) is a specialty research-driven biopharmaceutical firm focused on developing innovative formulations and novel drug-delivery systems across oncology, neurology, dermatology and ophthalmology. The company works on converting complex science into clinically useful therapies through proprietary platforms, including long-acting injectables and targeted delivery technologies. SPARC’s model relies on out-licensing, global partnerships and milestone-based revenues while maintaining a strong pipeline of NCEs and differentiated generics, aiming to create sustainable value through innovation-led R&D. Disclaimer: Investments in securities are subject to market risk. This is for educational purposes ***** must verify information before investing and consider their financial position & risk profile. please read full disclosure disclaimer in given link

#WatchOutFor

1,175 likes·25 comments